Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

CJC-1295 no DAC & Ipamorelin Body Recomposition: Timeline Comparison

Weeks 1–3 (Adaptation) GH receptor upregulation, improved sleep architecture, glycogen supercompensation Improved recovery, stable weight or slight increase, enhanced sleep quality Volume accumulation, technique refinement Maintenance calories, protein 1.6–2.2

This comparison does not assign a generated winner or score.

  • Weeks 1–3 (Adaptation)
  • GH receptor upregulation, improved sleep architecture, glycogen supercompensation
  • Improved recovery, stable weight or slight increase, enhanced sleep quality
  • Volume accumulation, technique refinement
  • Maintenance calories, protein 1.6–2.2 g/kg
  • Weeks 4–8 (Fat Loss Window)
  • Lipolysis activation via HSL, visceral fat mobilisation, RER shift toward fat oxidation
  • Visible abdominal fat reduction, waist circumference decrease, weight loss 0.5–1% per week
  • Progressive overload on key lifts, frequency 4–6×/week
  • Mild deficit (10–15% below TDEE), leucine threshold at each meal
  • Weeks 9–12 (Recomposition Peak)
  • Muscle protein synthesis elevation, nutrient partitioning optimisation, sustained lipolysis
  • Muscle definition increases, strength plateaus or improves slightly, body weight stabilises
  • Intensity focus, deload every 4th week
  • Maintenance or slight deficit, carb timing around training
  • Weeks 13–16 (Maintenance)
  • IGF-1 levels plateau, adaptive thermogenesis begins
  • Visual refinement continues, measurable changes slow
  • Maintenance volume, emphasise weak points
  • Reverse diet if extending protocol, otherwise transition to maintenance
  • Bottom Line
  • CJC-1295 no DAC & Ipamorelin body recomposition results timeline expect follows a predictable biphasic pattern: metabolic adaptation first (weeks 1–3), then visible fat loss (weeks 4–8), with peak muscle definition at 12–16 weeks. Success depends on peptide quality, dosing precision, and structured training. Not dose escalation.
  • The 12–16 week window represents the point of diminishing returns for most users. Extending beyond 16 weeks without a washout period increases adaptive thermogenesis (metabolic slowdown) and may reduce GH receptor sensitivity despite continued peptide administration.
  • Progressive resistance training (4–6 sessions/week, ≥70% 1RM on compounds) is non-negotiable for recomposition. Peptides alone produce fat loss without muscle gain.
  • Protein intake ≥1.6 g/kg, leucine threshold met at each meal (2.5–3 g), mild caloric deficit (10–20% below TDEE) maintained throughout. Aggressive deficits negate the muscle-sparing benefit of GH elevation.
More references

Related material